ImmuCell
ICCC
28 hedge funds and large institutions have $5.56M invested in ImmuCell in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 0 closing their positions.
12% more funds holding
Funds holding: 25 → 28 (+3)
1.57% more ownership
Funds ownership: 13.13% → 14.7% (+1.6%)
3% more capital invested
Capital invested by funds: $5.39M → $5.56M (+$163K)
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$499K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$114K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$44.6K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$12.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$12.2K |
| 3 |
WE
Wealth Effects
Boston,
Massachusetts
|
-$12K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8.54K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$6.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $63 | – | – | – |
|
|
IC
27
Innealta Capital
Austin,
Texas
| $5 | +$5 | +1 | New |
|
|
28
Wells Fargo
San Francisco,
California
| $3 | -$12.2K | -2,543 | -100% |
|
ICCC Hedge Fund Activity: Q2 2024 in Review
28 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2024, worth a combined $5.56M — up 3% from $5.39M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ICCC positions and 0 closed out — a net gain of 3 holders — while 8 added to existing stakes and 8 trimmed.
The largest buyer was Cresset Asset Management, adding an estimated $499K. The largest seller was Susquehanna International Group, cutting an estimated $21K.
- 28 institutional investors held ImmuCell (ICCC) as of Q2 2024, up from 25 in Q1 2024.
- Funds reported $5.56M of ImmuCell stock for Q2 2024, up 3% quarter-over-quarter.
- 3 funds opened new ImmuCell positions in Q2 2024 and 0 closed out, a net change of +3 holders.
- The largest ImmuCell buyer in Q2 2024 was Cresset Asset Management, an estimated $499K added.
- The largest ImmuCell seller in Q2 2024 was Susquehanna International Group, an estimated $21K sold.
Based on aggregated 13F filings for Q2 2024.